PRTA Prothena Corporation plc
Prothena Corporation plc (PRTA) is expected to report earnings on February 4, 2027, after the market close. The consensus earnings estimate is $0.00 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +1.3% since its last earnings release on November 5, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Prothena Corporation plc
Prothena Corp PLC is a biotechnology company. It discovers and develops novel antibodies for the potential treatment of a broad range of diseases that involve protein misfolding or cell adhesion.
Sector
Healthcare
Industry
Biotechnology
Held By 3 ETFs, by dollar flow
Charts powered in part by Lightweight Charts™ by TradingView.